1. Trichostatin A-induced Apoptosis is Mediated by Krüppel-like Factor 4 in Ovarian and Lung Cancer
   Sadeghi Zohre et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
2. Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
   Weiqiang Zhou et al, 2016, Scientific Reports CrossRef
3. Autophagy-related genes are induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid via the activation of cathepsin B in human breast cancer cells
   Han Han et al, 2017, Oncotarget CrossRef
4. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells
   Brian Tung et al, 2018, BMC Cancer CrossRef
5. Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
   Jianwei Feng et al, 2022, Frontiers in Pharmacology CrossRef
6. Histone Deacetylase Inhibition Downregulates Collagen 3A1 in Fibrotic Lung Fibroblasts
   Xiangyu Zhang et al, 2013, International Journal of Molecular Sciences CrossRef
7. Biological Effect of a Hybrid Anticancer Agent Based on Kinase and Histone Deacetylase Inhibitors on Triple-Negative (MDA-MB231) Breast Cancer Cells
   Mariangela Librizzi et al, 2016, International Journal of Molecular Sciences CrossRef
8. The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy
   Jessica Chacon et al, 2016, Vaccines CrossRef
9. Vorinostat (SAHA) and Breast Cancer: An Overview
   Anna Wawruszak et al, 2021, Cancers CrossRef
10. Use of Epigenetic Modulators as a Powerful Adjuvant for Breast Cancer Therapies
    Aurore Claude-Taupin et al, 2015, Cancer Epigenetics CrossRef
11. Vorinostat-loaded titanium oxide nanoparticles (anatase) induce G2/M cell cycle arrest in breast cancer cells via PALB2 upregulation
    Shaimaa Abdel-Ghany et al, 2020, 3 Biotech CrossRef
12. Immune checkpoint therapy in liver cancer
    Feng Xu et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
13. Soluble immune checkpoints in cancer: production, function and biological significance
    Daqian Gu et al, 2018, Journal for ImmunoTherapy of Cancer CrossRef
14. Effects of Valproic Acid on Proliferation, Apoptosis, Angiogenesis and Metastasis of Ovarian Cancer in Vitro and in Vivo
    Zhao Shan et al, 2012, Asian Pacific Journal of Cancer Prevention CrossRef
15. BRCA-Monet: a breast cancer specific drug treatment mode-of-action network for treatment effective prediction using large scale microarray database
    Chifeng Ma et al, 2013, BMC Systems Biology CrossRef
16. The Histone Deacetylase Inhibitor JAHA Down-Regulates pERK and Global DNA Methylation in MDA-MB231 Breast Cancer Cells
    Mariangela Librizzi et al, 2015, Materials CrossRef
17. 4-1BB and the Epigenetic Regulations of This Molecule
    Thien Chu-Dinh et al, 2014, Medical Epigenetics CrossRef
18. Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way
    Wei Li et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
19. Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study
    Stuart L. Cramer et al, 2018, Frontiers in Oncology CrossRef